• ChemFaces is a professional high-purity natural products manufacturer.
  • Product Intended Use
  • 1. Reference standards
  • 2. Pharmacological research
  • 3. Inhibitors
  • Home
  • Natural Products
  • Bioactive
  • Screening Libraries
  • Hot Products
  • Plant Catalog
  • Customer Support
  • Product Use Citation
  • About Us
  • Contact Us
  • Bioactive Products
    Dietary-supplement Compound Library
    A unique collection of 47 Dietary-supplement natural compounds for research
    Catalog No: F7 Dietary-supplement Compound Library
    Screening Details
    Size: 1mg/well * 47 Compounds
    2mg/well * 47 Compounds
    Catalog No. Information
    CFN99280 Limonin

    1. Limonin has anticancer activity.
    2. Limonin has antioxidant activity.
    3. Limonin has anti-inflammatory activity.
    4. Limonin is a widely used dietary supplement, one of the most prevalent citrus limonoids.
    5. Limonin has negligible inhibitory effects on human CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and P-gp.
    CFN99384 Lutein

    1. Lutein has antitumour action.
    2. Lutein has antimutagenic action.
    3. Lutein has a wide range of antimicrobial action.
    4. Lutein is potentially useful for treating macular degeneration.
    CFN99551 Synephrine

    1. Synephrine has anti-virus function.
    2. Synephrine has anti-allergy function.
    3. Synephrine has anti-inflammatory function.
    4. Synephrine was originally produced as a synthetic derivative of amphetamine for use as a sympathomimetic.
    5. Synephrine can treat hypertension and cardiovascular disease via increasing capillary toughness, lowering cholesterol.
    CFN99702 Zingerone

    1. Zingerone has antioxidant and anti-inflammatory properties.
    2. Zingerone is a suitable anti-virulent drug candidate against P. aeruginosa infections, because of the anti-quorum sensing activity of Zingerone targeting ligand-receptor interaction.
    3. Zingerone effectively inhibits DMH-induced colon carcinogenesis in male Wistar rats, and ACF formation with simultaneous modulation in the level of tissue lipid peroxidation and antioxidant status.
    CFN99722 Secoisolariciresinol Diglucoside

    1. Secoisolariciresinol Diglucoside was cytoprotective in an in vitro model of iron overload induced redox-inflammatory damage.
    2. Synthetic Secoisolariciresinol Diglucoside at 25 mg/kg b.w., exerts anti hyperglycemic effect by preventing the liver from peroxidation damage through inhibition of ROS level mediated increased level of enzymatic and non-enzymatic antioxidants.
    3. Secoisolariciresinol Diglucoside has renoprotective effects in HFD/STZ-induced DN in rats through correction of hyperglycemia.
    (1) Attenuation of oxidative/nitrosative stress markers;
    (2) Downregulation of renal expressions of inflammatory markers NF-κB, TNF-α, and iNOS;
    (3) Along with upregulation of renal expressions of antiapoptotic markers survivin and Bcl-2;
    (4) Maintain tissue function which results in improving the sensitivity and response of target cells in STZ-induced diabetic rats to insulin.